Novartis is a world leader in offering medicines to protect health, cure disease and improve well-being. Our goal is to discover, develop and successfully market innovative products to treat patients, ease suffering and to enhance the quality of life. We also seek to provide a return to shareholders that reflects our performance and to adequately reward those who invest ideas and resources in our company.
Lichtstrasse 35, 4002 Basel, Schweiz
Tel.: 0041 61 324 84 33
Fax: 0041 61 324 84 44
IR-Kontakt: Dr. Karen J. Hübscher
investor.relations@novartis.com
http://www.novartis.com/
